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Neural prosthetic implants are currently being developed for the treatment and study of both 
peripheral and central nervous system disorders. Effective integration of these devices upon 
implantation is a critical hurdle to achieving function. As a result, much attention has been 
directed towards the development of biocompatible coatings that prolong their in vivo lifespan. 
In this work, we present a novel approach to fabricate such coatings, which speciﬁ  cally involves 
the use of surface-adsorbed, nanoscale-designed protein polymers to prepare reproducible, 
customized surfaces. A nanoscale modular design strategy was employed to synthesize six 
engineered, recombinant proteins intended to mimic aspects of the extracellular matrix proteins 
ﬁ  bronectin, laminin, and elastin as well as the cell–cell adhesive protein neural cell adhesion 
molecule. Physical adsorption isotherms were experimentally determined for these engineered 
proteins, allowing for direct calculation of the available ligand density present on coated 
surfaces. As conﬁ  rmation that ligand density in these engineered systems impacts neuronal 
cell behavior, we demonstrate that increasing the density of ﬁ  bronectin-derived RGD ligands 
on coated surfaces while maintaining uniform protein surface coverage results in enhanced 
neurite extension of PC-12 cells. Therefore, this engineered protein adsorption approach allows 
for the facile preparation of tunable, quantiﬁ  able, and reproducible surfaces for in vitro studies 
of cell–ligand interactions and for potential application as coatings on neural implants.
Keywords: biocompatible, protein, adsorption, coatings, implants, neural, elastin
polymerization (Cui et al., 2001), covalent molecule attachment 
(Huber et al., 1998; Massia et al., 2004), self-assembling monolayers 
(Pakalns et al., 1999), microcontact printing (James et al., 1998), 
and surface adsorption of proteins and synthetic polymers (Elbert 
and Hubbell, 1996; Giorgetti et al., 2008; Wang, 2007).
Here we present a new approach to create enhanced neu-
ral implant bio-interfaces that offers nanoscale precision and is 
reproducible, simple to apply, quantiﬁ  able, and customizable. This 
approach involves the preparation of thin ﬁ  lms using   surface-
adsorbed, nanoscale-designed protein polymers (Heilshorn et al., 
2005). Our proteins are modular in design, consisting of alter-
nating structural and biofunctional nanoscale domains that are 
intended to mimic aspects of extracellular matrix (ECM) proteins 
(Heilshorn et al., 2003). The proteins are synthesized using recom-
binant, genetic engineering techniques, allowing for the creation 
of biocompatible polymers with nanoscale precision that impart 
highly speciﬁ  c protein functionalities. We make use of a highly 
ﬂ  exible multi-step cloning strategy in order to allow for the rapid 
synthesis of new recombinant proteins that can introduce many dif-
ferent biofunctionalities. The engineered proteins discussed in this 
work contain identical nanoscale structural domains, similar to a 
repeated sequence found in the ECM protein elastin, and have been 
designed to present different biofunctional nanodomains taken 
from the ECM proteins ﬁ  bronectin and laminin, and the cell–cell 
adhesion protein neural cell adhesion molecule (NCAM) (Meiners 
and Mercado, 2003; Soroka et al., 2002; Urry et al., 1991).
INTRODUCTION
Many recent experimental ﬁ  ndings have emphasized the impor-
tance of surface properties for the optimization and control of cell 
adhesion, morphology, motility, proliferation, and differentiation 
in both in vitro and in vivo systems (Gordon et al., 2007; Kasemo, 
2002; Stevens and George, 2005). Of speciﬁ  c interest is the role that 
nanoscale cell–surface interactions play in the biocompatibility of 
neural implants. Neural prosthetic implants have shown promise 
in applications involving recording neural activity and the stimula-
tion of function in both the central and peripheral nervous systems 
for the treatment of deafness and neurological diseases such as 
Parkinson’s and cerebral palsy (Branner et al., 2001; Gordon et al., 
2007; He and Bellamkonda, 2005; Kipke et al., 2003; Olanow et al., 
2000). A major roadblock in the success of these implants has been 
the effective integration of the implant surface with the surround-
ing tissue (Anderson et al., 2008).
Studies have shown that upon implantation of a foreign mate-
rial, proteins rapidly adsorb to the implant bio-interface and that 
these proteins greatly affect the subsequent cellular and inﬂ  am-
matory responses (Anderson et al., 2008; Wilson et al., 2005). As a 
result, implants are now routinely modiﬁ  ed to present thin nanos-
tructures on their surfaces that aim to selectively bind beneﬁ  cial 
molecules while minimizing non-speciﬁ  c adsorption (Ai et al., 
2003). Already established approaches for the fabrication of bio-
compatible implant surfaces include layer-by-layer electrostatic 
adsorption (Ai et  al., 2003; Ariga et  al., 2007), electrochemical 
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Proteins are widely accepted to be highly surface active molecules, 
and their adsorption afﬁ  nity to a given surface is determined by 
a combination of thermodynamic driving forces, such as electro-
static interactions and changes in system entropy due to structural 
alterations or protein/surface dehydration (Wilson et al., 2005). This 
phenomenon provides for a relatively simple surface adsorption 
approach that addresses many current limitations of existing bio-
active, thin-ﬁ  lm preparation techniques. Most of these techniques 
focus on enhancing implant biocompatibility by either grafting 
short peptides or entire ECM proteins to surfaces. Methods that 
involve grafting peptides to surfaces typically focus on applying a 
uniform layer of a particular ligand rather than speciﬁ  ed densities, 
are difﬁ  cult to quantify, often involve a complex series of steps, and 
can result in decreased biofunctionality due to restricted conforma-
tional ﬂ  exibility (Huber et al., 1998; Massia et al., 2004). In contrast, 
methods that rely on surface immobilization of entire ECM proteins 
suffer from difﬁ  culties in harvesting pure protein of a single splice 
variant and cannot be used to identify speciﬁ  c interactions integral 
for implant biocompatibility (El-Ghannam et al., 1998; Gray, 2004). 
Our surface modiﬁ  cation approach offers several key improvements, 
including the inherent simplicity of the protein adsorption proc-
ess, the relative ease of controlling and quantifying peptide ligand 
density, the design of conformational ﬂ  exibility into the polymer, 
and the ability to prepare combinatorial mixtures of nanodomains 
for the identiﬁ  cation of optimal peptide ligands and densities.
We ultimately intend to use this robust adsorption process to 
more rationally design optimized implant bio-interfaces that offer 
precise and customized nanoscale content and display either single 
or multiple peptide ligands. This manuscript presents the develop-
ment of these surfaces by ﬁ  rst introducing the modular design, syn-
thesis, and puriﬁ  cation of a set of recombinant, nanoscale-designed 
protein polymers from Escherichia coli bacteria. To demonstrate 
the ﬂ  exibility and robustness of this strategy, we designed, cloned, 
expressed, and puriﬁ  ed six new engineered proteins. These engi-
neered proteins were used to prepare adsorbed surfaces on glass 
substrates that exhibited controlled peptide content and similar 
surface saturation levels when quantiﬁ  ed with physical adsorp-
tion isotherms. The initial in vitro growth of neuronal-like PC-12 
cells on the adsorbed protein coatings exhibited a high level of 
cell–surface biocompatibility, and neurite elongation was shown to 
be directly correlated to the surface density of speciﬁ  c biofunctional 
nanodomains. These results set the stage for future combinatorial 
analysis of surface ligand compositions with potential applications 
in the study of cell–surface interactions in vitro or as neural implant 
bio-interfaces.
MATERIALS AND METHODS
PROTEIN SYNTHESIS AND PURIFICATION
Expression plasmids were constructed in pET15b vectors (Novagen) 
using multi-step recombinant DNA cloning techniques and trans-
formed into the E. coli expression strain BL21(DE3) (Straley and 
Heilshorn, 2009). Protein expression was induced under the control 
of the T7-lac promoter at an OD600 of about 0.6 (37°C, LB medium) 
with 1 mM β-isopropyl thiogalactoside and allowed to express for 
3-h post induction.
The RGD, RDG, NCAM, and NCAM Neg proteins were puri-
ﬁ  ed using an inverse temperature cycling process (Meyer and 
Chilkoti, 1999). For this process, the wet cell pellet was resuspended 
in TEN Buffer [1 g/mL and 1-mM phenylmethylsulphonyl ﬂ  uo-
ride (PMSF)], sonicated, and agitated overnight at 4°C. The pH 
was adjusted to 9 with 4 N NaOH, incubated at 4°C for 1 h, and 
centrifuged at 4°C. NaCl was added to the supernatant at a ﬁ  nal 
concentration of 1 M. This solution was agitated overnight at 4°C, 
incubated at 37°C shaking for 3 h, and centrifuged at 37°C. The 
pellet was resuspended in water (0.1 g/mL), agitated overnight at 
4°C, adjusted to a pH of about 9 with 1 N NaOH, incubated at 4°C 
shaking for 1 h, and centrifuged at 4°C. Warm (37°C, 1 M NaCl) 
and cold (4°C, pH ∼ 9) puriﬁ  cation cycles were each repeated twice. 
The ﬁ  nal supernatant was desalted using size exclusion centrifuga-
tion (10,000 MWCO, Millipore Amicon) and lyophilized. Typical 
protein yields were around 25–50 mg/L.
The lower critical solution temperature (LCST) transitions of the 
YIGSR and GRYSI proteins necessitated puriﬁ  cation using His-tag 
separation with nickel afﬁ  nity columns in order to achieve similar 
protein yields. For this process, the wet cell pellet was resuspended 
in native lysis buffer at 4°C (50-mM NaH2PO4, 300-mM NaCl, 
10-mM imidazole, pH = 8, 100-mL lysis buffer per 1-L original 
cell culture volume, 1-mM PMSF), sonicated, and centrifuged for 
30 min at 4°C. The supernatant was added to Ni-NTA afﬁ  nity resin 
(Qiagen, 0.25-mL resin/mL lysis buffer), incubated at 4°C shaking 
for 1 h, and gravity ﬁ  ltered in a protein column (4°C). The resin 
was washed twice with native wash buffer (50-mM NaH2PO4, 300-
mM NaCl, 20-mM imidazole, pH = 8, 100-mL wash buffer per 
1-L original cell culture volume, 4°C) and then the bound protein 
was eluted using native elution buffer (50-mM NaH2PO4, 300-mM 
NaCl, 250-mM imidazole, pH = 8, 50-mL elution buffer per 1-L 
original cell culture volume, 4°C). The ﬁ  nal eluent was concentrated 
and then buffer exchanged for water using size exclusion centrifuga-
tion (10,000 MWCO, Millipore Amicon, 4°C).
LOWER CRITICAL SOLUTION TEMPERATURE MEASUREMENT
Lyophilized protein was resuspended at a concentration of 10 mg/
mL in phosphate buffered saline (PBS, pH = 7.2, 4°C). Turbidity 
readings at 300 nm were monitored as a function of temperature 
using a Molecular Devices SpectraMax Plus384 Spectrophotometer. 
The temperature was increased at a rate of 0.1°C/min with an equi-
libration time of 30 s at each step.
SUBSTRATE PREPARATION
All adsorbed substrates were prepared on glass surfaces by dissolv-
ing lyophilized protein in PBS (pH = 7.4), pipetting these solutions 
on top of the glass surfaces, and incubating the samples overnight 
at 4°C. Control surfaces were similarly prepared using either no 
protein or 50-µg/mL rat tail collagen I (Sigma). The coverslips were 
then washed thrice with PBS buffer at room temperature.
BICINCHONINIC ACID ASSAY
Adsorbed protein substrates were prepared using the speciﬁ  ed pro-
tein concentrations as described above on glass-bottom 24-well 
plates (Matek) and covered with 250 µL of PBS and 250 µL of bicin-
choninic acid (BCA) assay working reagent (Sigma). Simultaneously, 
a set of standard solutions containing known concentrations of the 
protein of interest were prepared in PBS buffer (0, 0.5, 5, 10, 20, and 
30 µg/mL) and mixed with an equal volume of BCA working reagent. Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 3
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All reactions were sealed with tape and incubated for 1.5 h, shaking, 
at 50°C. The solutions were then equilibrated at room temperature 
for ∼20 min and absorbance readings were taken at 562 nm.
PC-12 CELL CULTURE
Adsorbed protein substrates were prepared as described above on 
sterile glass coverslips using protein solutions with 1-mg/mL total 
protein (1:0, 1:1, and 0:1 RDG:RGD protein), blocked with bovine 
serum albumin (BSA, fraction V, 0.2% in PBS, heat inactivated at 
85°C for 10 min) to prevent non-speciﬁ  c binding, and rinsed three 
times with PBS. PC-12 cells (ATCC) were prepared in F12 Kaighn’s 
complete media (10% horse serum, 5% fetal bovine serum, and 
1% penicillin-streptomycin) at 37°C, 5% CO2. Cells were added 
to the coverslips at a density of 15,000 cells/cm2 and differentiated 
in F12 Kaighn’s differentiation media [1% penicillin-streptomycin, 
50 ng/mL recombinant human β-NGF (R&D Systems)] for 6 days, 
at 37°C, 5% CO2. Media was changed every 2 days.
IMMUNOSTAINING
After 6 days of differentiation in F12 Kaighn’s differentiation media, 
samples were rinsed twice with PBS, ﬁ  xed with 4% paraformal-
dehyde in PBS for 15 min at room temperature, and rinsed twice 
more with PBS. Cells were permeabilized with 0.1% Triton X-100 
in PBS buffer (PBST, 15 min, room temperature), blocked with 
10% normal goat serum (PBST, 1 h, room temperature), and incu-
bated with rabbit monoclonal neuronal class III β-tubulin antibody 
(dilution factor of 1:500, Covance, PBST containing 5% normal 
goat serum, room temperature, 2 h). Samples were then rinsed 
with PBST, incubated with goat anti-rabbit IgG Alexa Fluor 488 
(Invitrogen, PBST containing 5% goat serum, 1 h), and rinsed with 
PBST. The samples were then incubated with 1 µg/mL of 4′,6-dia-
midino-2-  phenylindole (DAPI, Roche) in methanol for 15 min at 
37°C, washed with methanol, and mounted on microscope slides 
using Prolong Gold Antifade Reagent (Invitrogen). The ﬂ  uores-
cently labeled cells were visualized with an inverted Zeiss Axiovert 
200 microscope (40× objective) and digital images were captured 
with a CCD camera.
QUANTIFICATION OF NEURITE EXTENSION
Fluorescent images were obtained as described above. A total of 
20 images (total area = 7.22 mm2) were analyzed in triplicate for 
the 1:0, 1:1, and 0:1 RDG:RGD protein samples. For each image, 
cells with neurites greater than one cell diameter and cells with 
neurites greater than two cell diameters were counted. Statistical 
signiﬁ  cance between data sets was determined using a paired, two-
tailed Student’s t-test.
RESULTS
MATERIAL DESIGN AND SYNTHESIS
A schematic depicting the modular genetic design and exact amino 
acid content of our engineered proteins is shown in Figure 1; a 
total of six novel protein polymers were synthesized for subse-
quent study. Each recombinant protein contains two peptide tag 
sequences for identiﬁ  cation, an enterokinase cleavage site for tag 
removal, and four repeats of a sequence containing a nanoscale 
biofunctional domain followed by a nanoscale structural domain. 
The multi-step cloning strategy used to synthesize these proteins 
(Figure 2) ﬁ  rst required the design and commercial synthesis of 
oligonucleotide strands corresponding to each protein module. 
Single-stranded oligonucleotide sequences were designed to encode 
a speciﬁ  c domain sequence and to contain ﬂ  anking regions which 
introduced key enzyme restriction sites for the remainder of the 
cloning process (see Figure 1 in Supplementary Material for a 
detailed plasmid map). Each of these sequences was optimized 
for dominant codon usage in E. coli in an effort to increase ﬁ  nal 
protein expression yields.
As shown in Figure 2, the synthesis of the ﬁ  rst protein expres-
sion plasmid required a total of 11 steps (including annealing the 
synthetic oligonucleotide strands), but for each additional recom-
binant protein only six steps were required since the structural 
and tag sequences are identical. The multi-step cloning process 
makes use of two commercially available vectors, the high-copy 
number pUC18 cloning vector and the pET15b expression vec-
tor, which places a T7lac promoter upstream of the target pro-
tein sequence providing a mechanism for inducible expression 
T7 Tag His Tag EK Elastin-like Sequence
MASMTGGQQMG-HHHHH-DDDDK-LQ{LDAS-Biofunctional Site-SA[(VPGIG)
2VPGKG(VPGIG)
2]
3VP}
4LE
Protein  Name Biofunctional Site Sequence
RGD TVYAVTGRGDSPASSAA
RDG TVYAVTGRDGSPASSAA
NCAM AAGRILARGEINFAAA
NCAM Neg AAGRALARGEANFAAA
YIGSR VCDPGYIGSRCDDCAS
GRYSI VCDPGGRYSICDDCAS
See Table Below
FIGURE 1 | Amino acid sequences of the nanoscale-designed proteins (EK refers to an enterokinase cleavage site).Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 4
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in   bacterial   culture. In order to allow for   multimerization of the 
biofunctional and structural domains within the ﬁ  nal expression 
vector, SalI and XhoI restriction sites were positioned on either side 
of each repeated unit. This design takes advantage of the recognition 
properties of the SalI and XhoI restriction enzymes, which cut dif-
ferent DNA sequences but create identical sticky ends, thus allowing 
for repeated insertion of the domain sequences by destroying the 
previous XhoI sites. Directly following tetramerization of the bio-
functional and structural domains for each of the six proteins, the 
DNA sequence of the resultant expression plasmid was conﬁ  rmed 
with sequencing analysis.
The inherent ﬂ  exibility of this cloning strategy allowed for the 
custom preparation of six proteins containing different   nanoscale 
biofunctional peptide domains. In speciﬁ  c,  three  domains, 
pr  eviously shown to affect neuronal cell behavior, were selected 
for synthesis: the RGD domain of ﬁ  bronectin, the YIGSR domain 
in the β1 chain of laminin, and the P2 domain of NCAM. The 
RGD domain of ﬁ  bronectin, a protein found in the developing 
central nervous system at sites of axonal extension, has been previ-
ously shown to promote neurite attachment and elongation due 
to interaction with a variety of integrins displayed on the surfaces 
of neurites (Meiners and Mercado, 2003). The YIGSR domain of 
laminin, a protein that serves as a major component of the neu-
ronal basement membrane and that has been found to be present 
during development and upon injury, has been linked to increased 
neuronal attachment through interaction with an hypothesized 
Bioactive 
Domain
+
+
pUC18 Bio-pUC18
Bio-[Elastin]
3-pUC18
Tag-pET15b
Tag-[ Bio-[Elastin]
3]-pET15b
Tag-[Bio-[Elastin]
3]
4-pET15b
pET15b
EcoR1 
HindIII
KpnI
NcoI
XhoI
SalI 
XhoI
XhoI
T4 Ligase
XhoI
Elastin 
Domain
Tag      
Domain
XhoI
XhoI
FIGURE 2 | Multi-step cloning procedure for construction of protein expression plasmids (Tag: tag domain, Bio: biofunctional nanodomain, Elastin: 
structural nanodomain).Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 5
Straley and Heilshorn  Neuron-compatible adsorbed protein coatings
neuronal receptor homologous to one identiﬁ  ed in epithelial cells 
(Meiners and Mercado, 2003). The P2 peptide found in NCAM, a 
glycoprotein displayed on the surfaces of neuronal cells involved 
in cell–cell and cell–matrix interactions, has been shown to inhibit 
cellular aggregation and to increase neurite outgrowth (Soroka 
et al., 2002). Amino acid sequences beyond the minimal active pep-
tide sequence were used to construct the nanoscale biofunctional 
domains in order to promote bioactivity within the protein polymer 
by facilitating conformational ﬂ  exibility and potentially preserving 
the secondary structure of the peptide (Heilshorn et al., 2003). In 
addition, sequences corresponding to nanoscale negative controls 
of the RGD, YIGSR, and NCAM domains were incorporated into 
three additional proteins by either scrambling the primary amino 
acid sequence of the domain or including previously identiﬁ  ed 
negative sequences (Liu et al., 2004; Soroka et al., 2002).
All six proteins contain identical nanoscale structural domain 
content, which mimics the repeated VPGVG sequence found in the 
ECM protein elastin, a ﬁ  brous protein naturally found in connective 
tissue that possesses known properties of elasticity and resilience 
(Figure 1) (Nicol et al., 1992). The elastin-like sequence is not 
known to affect neuronal cell behavior and is, therefore, meant to 
serve as a relatively bio-inert backbone for the presentation of nano-
scale biofunctional peptide domains and to facilitate reproducible 
physical adsorption of the nanoscale-designed proteins. Previous 
characterization of elastin-like proteins have demonstrated bio-
compatibility, high expression levels in bacterial fermentations, 
and cost-effective puriﬁ  cation (Heilshorn et al., 2005; Meyer and 
Chilkoti, 1999).
The properties of these proteins allow for puriﬁ  cation using 
two different strategies, either a simple inverse temperature cycling 
technique or standard afﬁ  nity column puriﬁ  cation (Meyer and 
Chilkoti, 1999). The hydrophobic elastin-like structural sequence 
in the proteins causes the polymers to exhibit LCST behavior (Urry 
et al., 1992). At temperatures below the LCST, the proteins readily 
dissolve in water and at temperatures above the LCST, the proteins 
aggregate into a protein-rich coacervate, allowing for  puriﬁ  cation by 
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FIGURE 4 | Protein electrophoresis gels of puriﬁ  ed proteins. (A) RGD and RDG, (B) NCAM and NCAM Neg, (C) YIGSR, and (D) GRYSI.
centrifugation. The LCST behavior of the RGD protein is depicted 
in Figure 3, showing an LCST value of approximately 33.5°C. 
Based on previous work relating elastin-like sequences to LCST 
behavior, the elastin-like sequence VPGIG (Figure 1) was chosen 
to potentially allow for temperature cycling between 4°C (solubi-
lization) and 37°C (precipitation), convenient temperatures com-
monly found in a molecular biology laboratory (Urry et al., 1992). 
The inverse temperature cycling puriﬁ  cation procedure worked 
effectively for the RGD, RDG, NCAM, and NCAM Neg proteins, 
resulting in un-optimized yields of approximately 25–50 mg/mL. 
The properties of the YIGSR and GRYSI protein required His-tag 
afﬁ  nity column puriﬁ  cation to achieve similar yields. Purity of 
all nanoscale-designed recombinant proteins produced in E. coli 
bacteria was conﬁ  rmed using protein electrophoresis gels, Figure 4. 
The tag domains were left attached to all proteins in this work but Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 6
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biofunctionality of the nanoscale domains intended to bind with 
speciﬁ  c cell–surface receptors. As an initial demonstration of in 
vitro cell–surface biocompatibility, a clonal line of rat pheochro-
mocytoma cells known as PC-12 cells were grown on adsorbed 
could be removed in future applications through cleavage with 
enterokinase.
QUANTIFICATION OF ADSORBED PROTEIN SURFACES
The hydrophobic nature of the nanoscale elastin-mimetic domain 
was hypothesized to enable formation of reproducible thin ﬁ  lms of 
engineered proteins through simple physical adsorption. To probe 
this technique, thin ﬁ  lms of adsorbed, engineered proteins were 
prepared on glass substrates by dissolving puriﬁ  ed protein in PBS 
buffer (pH = 7.4) at known concentrations and incubating these 
solutions on surfaces overnight at 4°C, a temperature at which the 
proteins are known to be soluble. Following adsorption, the surfaces 
were thoroughly washed to remove any unbound protein polymers. 
Adsorbed protein content was quantiﬁ  ed by performing the BCA 
protein concentration assay (Heilshorn et al., 2005; Ishii-Watabe 
et al., 2007; Puleo et al., 2002; Shoichet et al., 1994). In this assay, 
polypeptides (more than three peptide bonds) reduce a copper 
reagent (Cu2+ to Cu1+) within an alkaline medium, and the reduced 
copper state is detected by a sensitive colorimetric detection reagent. 
The spectrophotometric absorbance (λ = 562 nm) of the reacted 
solution is proportional to the amount of protein present on the 
surface; the absolute concentration is determined using soluble 
calibration standards of the protein of interest (Heilshorn et al., 
2005; Ishii-Watabe et al., 2007; Puleo et al., 2002; Shoichet et al., 
1994; Stich, 1990).
Physical adsorption isotherms were prepared using this assay 
for the RGD, YIGSR, and NCAM proteins by adsorbing proteins 
on glass surfaces using solutions containing 0–6 mg/mL protein, 
Figure 5. Despite differences in their bioactive domain content, 
the engineered proteins adsorbed to the glass substrate at similar 
saturation levels, 30–44 ng/mm2, suggesting that the hydrophobic 
nature of the nanoscale elastin-mimetic structural domains and/or 
the overall protein molecular weight may be the primary driving 
forces for physical adsorption.
Since recombinant protein production of rationally-designed 
proteins offers precise, nanoscale control over polymer content, the 
surface concentration of adsorbed, engineered protein is directly 
related to the surface concentration of available ligand; one pro-
tein polymer presents four nanoscale biofunctional domains. This 
high level of control over protein synthesis and the availability of a 
simple quantiﬁ  cation reaction allows for the facile preparation of 
coated surfaces with reproducible and known biofunctional ligand 
concentrations. The amount of ligand present on a surface can be 
further tuned by preparing combinatorial surfaces containing mix-
tures of proteins with different nanoscale biofunctional domains, 
including the negative control domain sequences. This approach 
to fabricating bioactive surface coatings avoids techniques involv-
ing grafting synthetic peptides, which are difﬁ  cult to control and 
quantify and often have limited biofunctionality, or immobiliz-
ing harvested ECM proteins, which present a complicated array 
of cell–surface interactions and may be present as multiple splice 
variants, confounding experimental results and complicating data 
analysis and reproducibility.
PC-12 CELL CULTURE ON ADSORBED PROTEIN SURFACES
The effective use of these surface-adsorbed proteins as neural 
implant coatings requires biocompatibility with neuronal cells and 
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 accomplished by preparing protein adsorption solutions containing 
a constant amount of total protein (1 mg/mL) but different ratios 
of RGD and RDG protein (1:0, 1:1, 0:1 RDG:RGD). Since the RGD 
and RDG proteins have the exact same amino acid composition, 
equivalent glass adsorption amounts can be accurately assumed for 
both polymers. This experimental design allows systematic tun-
ing of the RGD biofunctional domain density while maintaining 
a uniform coverage of protein surface concentration. Therefore, 
effects of speciﬁ  c cellular interactions with the RGD biofunctional 
domain can be independently isolated from non-speciﬁ  c, physical 
cell–protein interactions.
Adsorbed surfaces were prepared on coverslips as described 
above and were again blocked with BSA; collagen positive-control 
surfaces and BSA negative-control surfaces were also prepared. PC-
12 cells were differentiated on these ﬁ  lms with 50 ng/mL NGF, 
and after 6 days, phase contrast images were taken of each surface 
sample; representative images are shown in Figure 7. The available 
RGD ligand density was calculated for each substrate assuming a 
total protein surface concentration of 28.6-ng protein per mm2, the 
value measured for an adsorbed surface prepared from a 1-mg/mL 
solution of RGD protein (Figure 5A). The quantiﬁ  ed RGD ligand 
densities were determined to be 0, 0.91, and 1.82 RGD peptides/nm2 
for the substrates prepared from 1:0, 1:1, 0:1 RDG:RGD solutions, 
respectively.
PC-12 cell adhesion on the thin ﬁ  lm containing a surface 
concentration of 1.82 RGD biofunctional nanodomains per nm2 
showed enhanced cell adhesion relative to the negative BSA control 
but exhibited lower levels of cell adhesion and increased aggregation 
RGD and collagen surfaces; adsorbed collagen is commonly used to 
promote adhesion of neuronal-like PC-12 cells (Banker and Goslin, 
1998) and has been considered for use in coating neural implants 
to enhance biocompatibility (Zhong et al., 2001). While PC-12 cells 
are known to sometimes behave differently from primary neurons, 
they are often utilized for the preliminary evaluation of biomaterials 
(Arien-Zakay et al., 2009; Cheng et al., 2003; Gunn et al., 2005).
Adsorbed protein ﬁ  lms were prepared by dissolving RGD pro-
tein (1 mg/mL) and collagen in PBS buffer and incubating these 
solutions on glass coverslips overnight, at 4°C. These surfaces 
were then thoroughly washed and blocked with BSA to prevent 
non- speciﬁ  c cell adhesion. PC-12 cells were differentiated on the 
coverslips in the presence of 50 ng/mL nerve growth factor (NGF). 
Following 6 days of culture, the cells were analyzed for morpho-
logical differences between the engineered surfaces and the col-
lagen positive-control surfaces using immunostaining (Figure 6). 
Positive staining for neuron-speciﬁ  c β-tubulin on both surfaces 
indicated that the engineered surfaces supported cell proliferation, 
neuronal differentiation, and neurite outgrowth, and no evidence 
of cytotoxicity was observed.
TUNING CELLULAR RESPONSES THROUGH COMBINATORIAL 
PRESENTATION OF ENGINEERED PROTEINS
Once initial biocompatibility was established, the surface-adsorbed 
engineered proteins were further evaluated for their ability to 
control cell behavior by tuning ligand surface composition. In 
speciﬁ  c, adsorbed protein surfaces were prepared that contained 
variable nanoscale RGD biofunctional domain density. This was 
A
B
50 µm
Collagen
RGD
FIGURE 6 | Representative ﬂ  uorescent images of PC-12 cells differentiated for 6 days on (A) adsorbed collagen and (B) adsorbed RGD protein; nuclei 
stained with DAPI in blue, cytoplasm stained with neuron-speciﬁ  c β-tubulin in green.Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 8
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levels relative to the positive collagen control. This is an expected 
result, since the RGD ﬁ  lms display only a single biofunctional nano-
domain, while the collagen surfaces are known to display multiple 
beneﬁ  cial nanodomains. Also readily apparent in the phase contrast 
images (Figure 7) is the considerable difference in the number of 
neurites extended on the engineered surfaces as a function of RGD 
domain density. Image analysis and quantiﬁ  cation from 20 ﬁ  elds 
of view, n = 3, (Figure 8) demonstrated that PC-12 cells exhib-
ited a statistically signiﬁ  cant increase in total neurite extension 
(neurite length > 1 cell body diameter) and neurite length (neu-
rite length > 2 cell body diameters) with increasing RGD surface 
concentration and that the highest level of neurite extension was 
achieved on the positive collagen control.
DISCUSSION
The ultimate goal of this research is to create more reproducible, 
customizable, and quantiﬁ  able surface coatings, which can further 
enhance the biocompatibility of neural implants by studying spe-
ciﬁ  c cell–surface interactions. In this work, we have presented the 
design and synthesis of six recombinant, nanoscale-designed pro-
teins that display various biofunctional ligands within an identical 
and relatively bio-inert elastin-mimic backbone. The speciﬁ  c bio-
functional nanodomains chosen for integration within the ration-
ally-designed proteins were derived from the naturally occurring 
proteins ﬁ  bronectin, laminin, and NCAM and have been previously 
shown to both enhance neuronal cell adhesion and increase neurite 
extension. These engineered proteins were synthesized using a care-
fully designed sequence of ﬂ  exible but robust cloning steps, making 
them highly amenable to sequence customization for the presenta-
tion of other biofunctional ligand domains already identiﬁ  ed in 
the literature (Meiners and Mercado, 2003). Using this framework, 
additional proteins can be easily engineered to display ligands that 
may play important roles in controlling the inﬂ  ammatory response 
upon implantation of a neural device.
Due to a combination of thermodynamic interactions, most 
proteins show high surface afﬁ   nity and are, therefore, easily 
adsorbed to surfaces via physical interactions (Hlady and Buijs, 
1996; Nakanishi et al., 2001; Wahlgren and Arnebrant, 1991; Wilson 
et al., 2005). The adsorption process is very robust and as a result 
can be uniformly applied to implant surfaces of various shapes. In 
particular, the use of adsorbed engineered proteins allows for the 
preparation of surfaces with highly reproducible and quantiﬁ  able 
nanoscale ligand content. Such precision is made possible by the 
inherent, molecular-level control over protein composition offered 
by recombinant bacterial expression. Unlike ECM proteins har-
vested from natural mammalian sources, these nanoscale-designed 
proteins contain a known number of speciﬁ  c biofunctional ligands, 
and this relationship can be used to experimentally determine avail-
able ligand density on adsorbed surfaces using a straightforward 
and potentially high-throughput protein concentration assay. 
The rational-protein-design strategy also enables the incorpora-
tion of novel nanoscale ligands, such as the P2 domain of NCAM 
included here, that are not normally presented within the natural 
ECM. Physical adsorption isotherms were prepared for the RGD, 
YIGSR, and NCAM proteins and revealed similar levels of protein 
surface saturation independent of biofunctional domain content. 
This strategy will enable the preparation of surface coatings with 
controlled surface concentrations of multiple nanoscale ligands for 
speciﬁ  c cell–material interactions. The ability to accurately charac-
terize and control surface content across a wide variety of potential 
ligands is a signiﬁ  cant improvement over current techniques that 
involve grafting peptides or entire ECM proteins.
100 µm
Collagen A
B
C
D
E
1.82 RGD/nm
2
0.91 RGD/nm
2
0 RGD/nm
2
BSA
FIGURE 7 | Phase contrast images of PC-12 cells differentiated for 6 days 
on control substrates and adsorbed protein ﬁ  lms with varying RGD 
biofunctional nanodomain density and uniform overall protein 
surface coverage. (A) Collagen, (B) 1.82 RGD peptides/nm2, (C) 0.91 RGD 
peptides/nm2, (D) 0 RGD peptides/nm2, and (E) BSA.Frontiers in Neuroengineering  www.frontiersin.org  June  2009 | Volume  2 | Article  9 | 9
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Initial studies of these nanoscale-designed protein surfaces in 
two-dimensional, in vitro PC-12 cell culture experiments dem-
onstrated a high level of cell–surface biocompatibility and similar 
cellular morphology to that seen on collagen positive-control 
surfaces. Also important for eventual in vivo application is ligand 
biofunctionality within the engineered protein coating so that 
the surfaces can be used to stimulate cell behavior. It was shown 
that by simply increasing the density of nanoscale RGD domains 
within a surface coating of uniform protein coverage, PC-12 neu-
rite extension was signiﬁ  cantly increased. Future studies involving 
known mixtures of multiple ligands and varied ligand densities 
with more therapeutically relevant neuronal cell lines will be 
conducted to help elucidate the optimal surface composition for 
a given neural implant application. In order to fully character-
ize these combinatorial ligand displays, techniques must ﬁ  rst be 
developed to accurately quantify the presence of multiple ligands 
on a single surface. The additional NCAM and YIGSR proteins 
introduced in this work represent initial efforts toward this goal 
and serve to demonstrate the versatility of our protein-design 
strategy for inclusion and presentation of a variety of biofunc-
tional ligands within a standardized biocompatible polymer.
Taken together, these results provide much motivation for the 
future study and characterization of surface-adsorbed, nanoscale-
designed proteins. Thin ﬁ  lm coatings prepared by physical adsorp-
tion of engineered proteins possess highly desirable properties such 
as sequence tunability, reproducible surface content, multiple lig-
and display, and quantiﬁ  able ligand density. These coatings have 
demonstrated their use as a reproducible, quantiﬁ  able, and tunable 
strategy to directly affect cellular behavior and show potential for 
many future applications including in vitro cell screening, fun-
damental studies of cell–ligand interactions, and eventual use as 
biocompatible in vivo coatings for neural implants.
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FIGURE 8 | Quantiﬁ  cation of PC-12 neurite extension after 6 days of differentiation on collagen positive-control substrates and adsorbed protein ﬁ  lms 
with varying RGD biofunctional nanodomain density and uniform overall protein surface coverage. (A) Percentage of cells with neurites > 1 cell body 
diameter. (B) Percentage of cells with long neurites > 2 cell body diameters. Substrates are statistically different, p < 0.04.
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